Summit Therapeutics's total assets for Q1 2025 were £383.82M, a decrease of -11.88% from the previous quarter. SMMT total liabilities were £39.49M for the fiscal quarter, a -15.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.